Evogene Ltd 20-F for FY2023
Evogene Ltd. (EVGN)
20-F
2024-03-28
For: 2023-12-31
View Original
Added on
April 05, 2026
About this 20-F
Evogene Ltd filed this 20-F on March 28, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $5.64M
- up 236.7% from $1.68M a year earlier
- Net loss
- $23.88M
- compared with a net loss of $26.64M a year earlier
- Diluted EPS
- -$0.52
- compared with -$0.65 a year earlier